International Clinical Trial: Research on the Value of Intensive Ablation Strategy in the Treatment of Paroxysmal Atrial Fibrillation

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128692) titled 'Research on the Value of Intensive Ablation Strategy in the Treatment of Paroxysmal Atrial Fibrillation' on July 24.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Shantou University Medical College

Condition: Paroxysmal Atrial Fibrillation

Intervention: PVI enhanced ablation + SVC isolation group:PVI enhanced ablation + superior vena cava isolation (SVCI)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: PVI enhanced ablation + SVC isolation group:175;PVI standard ablation group:175;

Cou...